Ocean Biomedical appoints Jolie Kahn as CFO effective March 1; predecessor Kalra resigned Jan 30

Ocean Biomedical, Inc.

Gurinder Kalra resigned as CFO effective January 30, 2024 to pursue other interests.
Jolie Kahn was confirmed as CFO on March 1, 2024; she also serves as legal counsel to the company.
Kahn has corporate finance and securities law background; prior CFO roles at GlucoTrack (2019-2023) and interim CFO at ToughBuilt.
Compensation: $22,500 per month for CFO and counsel services.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jolie Kahn

Chief Financial Officer

OCEA · Ocean Biomedical, Inc.

Effective: 2024-03-01
Filed: March 4, 2024, 6:59 PM ET

On March 1, 2024, the appointment of Jolie Kahn, as Chief Financial Officer of Ocean Biomedical, Inc. (the “Company”) was confirmed.

Departed

Gurinder Kalra

Chief Financial Officer

OCEA · Ocean Biomedical, Inc.

Effective: 2024-01-30
Successor: Jolie Kahn
Filed: March 4, 2024, 6:59 PM ET

Ms. Kahn replaces Gurinder Kalra who resigned effective January 30, 2024 to pursue other interests.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jolie Kahn was appointed as Chief Financial Officer at Ocean Biomedical, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 1, 2024, the appointment of Jolie Kahn, as Chief Financial Officer of Ocean Biomedical, Inc. (the “Company”) was confirmed.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Gurinder Kalra resigned as Chief Financial Officer at Ocean Biomedical, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Ms. Kahn replaces Gurinder Kalra who resigned effective January 30, 2024 to pursue other interests.

View on SEC.gov

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-008720

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.